Apr 4, 2022 | Lecture

How to improve conventional cystoscopy for bladder cancer diagnosis and follow-up?

Watch the case presentation of Dr. Ekaterina Laukhtina (Moscow, Russia)

At the 19th Meeting of the EAU Section of Oncological Urology (ESOU22), held on 21-23 January 2022 in Madrid, Spain, Dr. Ekaterina Laukhtina presented a case with non-muscle invasive bladder cancer (NMIBC) to discuss standard and new diagnostic and follow-up procedures with an international expert panel.

The expert panel consisted of ‪ Prof. Morgan Rouprêt (Paris, France), Prof. Fred Witjes (Nijmegen, The Netherlands), Dr. Mario Álvarez-Maestro (Madrid, Spain) and Dr. Luis Martínez-Piñeiro (Madrid, Spain).

Watch this presentation to learn more about:

  • Standard procedures in the diagnostic setting
  • The role of enhanced imaging techniques (photodynamic diagnosis [PDD] and narrow-band imaging [NBI]) for transurethral resection of bladder tumour (TURBT)
  • The advantages of using urinary biomarker tests in the follow-up of NMIBC
  • Alternatives for patients who refuse cystoscopy during follow-up

Other updates

The diagnostic value of urinary biomarkers in UTUC

Reviewed by Mr. Hugh Mostafid (Royal Surrey County Hospital, Guildford, UK) UTUC: similarities and differences compared to bladder cancer While bladder tumours account for 90-95% of all urothelial carcinomas (UCa), only 5-10% of UCa cases involve the upper urinary...

read more

Pin It on Pinterest